'. '' The goal of the MSTP at the University of Washington (UW) is to inspire, mentor, and train the next generation of outstanding medical research scientists. The UW MSTP began 38 years ago and now enrolls 12 new students annually. Our graduates have made important contributions to biomedical research and the practice of medicine and populate the highest rungs of academic ranks both locally and nationally. The co-directors (Lpeb and King) and administrator (Holstad) have 50 years combined experience with the UW MSTP. Two new associate directors (Horwitz and Clowes) joined the UW MSTP last year. PhD disciplines most popular with UW MSTP students are genome sciences, neurobiology, bioengineering, and molecular and cell biology. Student training is guided by a core faculty of 74 tenured professors (21 MD/PhD, 37 PhD, 11 MD), all with NIH-supported research. These core faculty are selected from >1000 professors;new faculty are integrated frequently. Students work in laboratories at the UW, the Fred Hutchinson Cancer Research Center (FHCRC), and the Seattle Biomedical Research Institute. Special programs dedicated to MSTP trainees, and extremely well-attended, include monthly dinner seminars, student-led biweekly journal club, continuity clerkships during research years, a post-PhD short course for re-orientation to clinical clerkships, evening programs devoted to each of the critical choices of MSTP life (of dissertation mentor, clerkships, residency, and postdoc), annual summer retreats, and ski trips and hiking expeditions. More than eighty-six percent of our graduates are pursuing careers in medical research. NIH how supports 29 of the 88 UW MSTP trainees. Contributions from the UW School of Medicine, from private donors in Seattle, and from research and training support to faculty mentors more than double this support, enabling full funding of all students throughout MD and PhD years. With this renewal, we request NIH support for 6 additional positions, to a total of 35 NIH-supported students, permitting 14 trainees to be enrolled each year. The UW and the FHCRC are currently in a period of extraordinary growth, particularly in genome sciences and bioengineering, fields of choice for increasing numbers of MSTP students. This infrastructure provides local resources to complement additional NIH support so as to create and maintain an MSTP cohort of approximately 100 trainees in all phases of the program.

Public Health Relevance

The University of Washington Medical Scientist Training Program integrates education in biomedical research with the clinical practice of medicine, leading to combined M.D. and Ph.D. degrees. Its students represent an elite cadre drawn from a highly qualified pool of applicants demonstrating academic promise and a commitment to scientific inquiry and patient care. Now in its 38th year, with 33 years of NIH funding, the UW MSTP, backed by enormous institutional scientific and clinical resources, has trained a generation of translational physician-scientists who have made signal discoveries profoundly contributing to the advancement of medicine.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Institutional National Research Service Award (T32)
Project #
5T32GM007266-39
Application #
8500310
Study Section
National Institute of General Medical Sciences Initial Review Group (BRT)
Program Officer
Preusch, Peter C
Project Start
1975-07-01
Project End
2014-06-30
Budget Start
2013-07-01
Budget End
2014-06-30
Support Year
39
Fiscal Year
2013
Total Cost
$1,256,371
Indirect Cost
$59,432
Name
University of Washington
Department
Pathology
Type
Schools of Medicine
DUNS #
605799469
City
Seattle
State
WA
Country
United States
Zip Code
98195
Reid-Bayliss, Kate S; Loeb, Lawrence A (2017) Accurate RNA consensus sequencing for high-fidelity detection of transcriptional mutagenesis-induced epimutations. Proc Natl Acad Sci U S A 114:9415-9420
Li, Lei; Li, Jing; Drum, Benjamin M et al. (2017) Loss of AKAP150 promotes pathological remodelling and heart failure propensity by disrupting calcium cycling and contractile reserve. Cardiovasc Res 113:147-159
Turner, Tychele N; Yi, Qian; Krumm, Niklas et al. (2017) denovo-db: a compendium of human de novo variants. Nucleic Acids Res 45:D804-D811
Sommermeyer, D; Hill, T; Shamah, S M et al. (2017) Fully human CD19-specific chimeric antigen receptors for T-cell therapy. Leukemia 31:2191-2199
Zheng, Grace X Y; Terry, Jessica M; Belgrader, Phillip et al. (2017) Massively parallel digital transcriptional profiling of single cells. Nat Commun 8:14049
Ashenberg, Orr; Padmakumar, Jai; Doud, Michael B et al. (2017) Deep mutational scanning identifies sites in influenza nucleoprotein that affect viral inhibition by MxA. PLoS Pathog 13:e1006288
Asiimwe, Stephen; Ross, Jennifer M; Arinaitwe, Anthony et al. (2017) Expanding HIV testing and linkage to care in southwestern Uganda with community health extension workers. J Int AIDS Soc 20:21633
Younis, Arwa; Eskenazi, Dana; Goldkorn, Ronen et al. (2017) The addition of vildagliptin to metformin prevents the elevation of interleukin 1ß in patients with type 2 diabetes and coronary artery disease: a prospective, randomized, open-label study. Cardiovasc Diabetol 16:69
Geisheker, Madeleine R; Heymann, Gabriel; Wang, Tianyun et al. (2017) Hotspots of missense mutation identify neurodevelopmental disorder genes and functional domains. Nat Neurosci 20:1043-1051
Burwick, Nicholas; Zhang, Michael Y; de la Puente, Pilar et al. (2017) The eIF2-alpha kinase HRI is a novel therapeutic target in multiple myeloma. Leuk Res 55:23-32

Showing the most recent 10 out of 366 publications